Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 2

Pimecrolimus cream in the management of patients with atopic eczema

Authors Spergel J

Published 19 May 2009 Volume 2009:2 Pages 85—93

DOI https://doi.org/10.2147/CCID.S3377

Review by Single anonymous peer review

Peer reviewer comments 3


Jonathan M Spergel

Division of Allergy and Immunology, The Children’s Hospital of Philadelphia Department of Pediatrics, University of Pennsylvania School of Medicine

Abstract: Atopic eczema is a common pediatric skin disorder. This review examines the use of pimecrolimus cream in the treatment of acute and chronic stages of the disease. The standard therapy is the treatment of acute flares with topical medications including pimecrolimus. The use of pimecrolimus cream for the first sign and symptoms of atopic eczema reduces the occurrence of flares as defined by the need for topical corticosteroids. The side effects of pimecrolimus cream are mild without any increase of infections or systemic immune suppression.

Keywords: pimecrolimus, atopic eczema, long-term management

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]